Clik here to view.
Masimo宣布rainbow®多波长脉搏灌注变异指数无创RPVi™获得CE标记
瑞士纳沙泰尔 (美国商业资讯) — Masimo (NASDAQ: MASI)今天宣布，RPVi™获得CE标记，RPVi是一个或多个呼吸周期中灌注指数(Pi)所发生的动态变化的无创连续测量指标。RPVi可显示某些生理因素（例如血管张力、循环血容量、胸内压位移）的变化。 Smart News Releases（智能新闻稿）是一个多媒体平台。在此处查看完整新闻稿：...
View ArticleClik here to view.
マシモ、rainbow®対応の多派長脈波変動指標となる非侵襲的RPVi™のCEマーク取得を発表
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は本日、RPVi™がCEマークを取得したと発表しました。RPVi™は、1回以上の呼吸周期における灌流指標（Pi）の動的変化を非侵襲的かつ連続的に測定した値です。RPViは血管緊張度、循環血液量、胸腔内圧変動などの生理学的因子を反映した変化を示すようにデザインされています。 このSmart News...
View ArticleClik here to view.
Samsung Bioepis Announces RENFLEXIS™ (infliximab-abda) Now Available in the...
INCHEON, Korea Samsung Bioepis Co., Ltd. today announced the launch of RENFLEXIS™ (infliximab-abda), a biosimilar referencing Remicade® (infliximab), in the United States (US). RENFLEXIS™ was...
View ArticleClik here to view.
Co-Diagnostics, Inc. Announces Joint Venture in India
SALT LAKE CITY Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company that has a unique, proprietary platform for the development of diagnostic...
View ArticleClik here to view.
Sulzer: Counterfeiters and Patent Infringers at the IDS 2017 – Sulzer Mixpac...
HAAG, Switzerland & COLOGNE, Germany Sulzer Mixpac Ltd (SULZER) operates globally in the field of static mixing tips, cartridges and dispensing devices for the dental sector. In recent times,...
View ArticleClik here to view.
Hoya Reports First Quarter Financial Results
TOKYO HOYA Corporation (TOKYO:7741) today announced financial results for the first quarter ended June 30, 2017. During the quarter, revenues increased 10.4% year on year, reaching 127,158 million...
View ArticleClik here to view.
Dr. Reddy’s Q1 FY18 Financial Results
HYDERABAD, India Dr. Reddy’s Laboratories Ltd. (NYSE: RDY | BSE: 500124 | NSE: DRREDDY) today announced its consolidated financial results for the first quarter ended June 30, 2017 under...
View ArticleClik here to view.
Dr. Reddy’s and CHD Bioscience Announce Global License and Commercialization...
FORT COLLINS, Colo. & PRINCETON, N.J. & HYDERABAD, India Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) and CHD Bioscience Inc., a privately-held biopharmaceutical...
View ArticleClik here to view.
苏尔寿：IDS 2017出现仿冒品和专利侵权者——苏尔寿混合技术有限公司将继续行使其权利
瑞士哈格与德国科隆 (美国商业资讯)–苏尔寿混合技术有限公司（Sulzer Mixpac Ltd，简称苏尔寿）在全球经营牙科领域的静态混合管、卡筒和胶枪。最近，公司发现了越来越多用于双组份卡筒和注射管的高仿静态混合器。这些由其他制造商生产的仿冒品并未得到SULZER严格的质量控制，因此不在公司的保修范围之内。本着客户的利益，SULZER将继续采取法律行动，打击此类仿冒行为。 Smart...
View ArticleClik here to view.
Astellas Reports First Quarter FY2017 Financial Results
TOKYO Astellas Pharma Inc. (TOKYO:4503)(President and CEO: Yoshihiko Hatanaka, “Astellas”) today announced the financial results for the first quarter of fiscal year 2017 (“FY2017”), ending March...
View ArticleClik here to view.
Takeda Reports 1st Quarter FY2017 Results
OSAKA, Japan Takeda Pharmaceutical Company Limited (TOKYO:4502): Underlying Revenue growth of 6.6% led by Takeda’s Growth Drivers Underlying Revenue grew +6.6% with growth across all regions (U.S....
View ArticleClik here to view.
武田薬品: 2017年度第1四半期の連結業績について
大阪 （ビジネスワイヤ） — 武田薬品工業株式会社 （東証：4502）： 実質的な売上収益の成長は6.6％の増収、成長ドライバーが牽引...
View ArticleClik here to view.
武田公布2017财年第一季度业绩
日本大阪 (美国商业资讯)–武田药品工业株式会社(Takeda Pharmaceutical Company Limited)(TOKYO: 4502)： 武田增长引擎带动基础营收增长 6.6% 基础营收增长+6.6%，各地区业务均有所增长（美国+13.5%、日本 +1.6%、欧洲与加拿大 +4.6%、 新兴市场...
View ArticleClik here to view.
Celltrion and Teva Announce U.S. FDA Acceptance of Biologics License...
INCHEON, Republic of Korea & JERUSALEM Celltrion, Inc. and Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that the U.S. Food and Drug Administration (FDA) has accepted...
View ArticleClik here to view.
Takeda and Cardurion Pharmaceuticals Launch Cardiovascular Development...
OSAKA, Japan & CAMBRIDGE, Mass. Takeda Pharmaceutical Company Limited (TSE: 4502) and Cardurion Pharmaceuticals today announced the creation of a new cardiovascular development partnership....
View ArticleClik here to view.
Saphetor and Supratech Leverage Genome Scale Analyses to Facilitate Precision...
LAUSANNE, Switzerland Saphetor SA, the Swiss precision-medicine company dedicated to advancing personalized diagnostics, announced today that it will provide its proprietary platform for analyzing...
View ArticleClik here to view.
Takeda and Molecular Templates Announce Multi-Target Research and Licensing...
OSAKA, Japan & AUSTIN, Texas Takeda Pharmaceutical Company Limited (TSE: 4502) and Molecular Templates, Inc. today announced a collaboration agreement for oncology drug discovery programs. The...
View ArticleClik here to view.
Swift Biosciences Announces New Industry-Leading Indexed Adapters for...
ANN ARBOR, Mich. Swift Biosciences, a leading provider of innovative library prep solutions for genomic sequencing, today announced the launch of Accel-NGS® 2S Indexed Adapters, a new portfolio of...
View ArticleClik here to view.
Swift Biosciences发布业界领先的新款标引接头，单次运行可测序的样本更多
密歇根州安娜堡 (美国商业资讯) — Swift Biosciences是面向基因组测序的创新文库制备解决方案的领先提供商，该公司今天宣布上市Accel-NGS®...
View ArticleClik here to view.
スウィフト・バイオサイエンシズ、1回のランで多数のサンプルをシーケンスできる業界最高レベルの新しいインデックス付きアダプターを発表
米ミシガン州アナーバー （ビジネスワイヤ）–ゲノムシーケンス用の革新的なライブラリー調製ソリューションを提供する一流のスウィフト・バイオサイエンシズは本日、Accel-NGS® 2Sインデックス付きアダプターの市場投入を発表しました。Accel-NGS®...
View Article